Medication therapy management services: Definitions and outcomes

Drugs

Volumn 69, Issue 4, 2009, Pages 393-406

  Pellegrino, Annette N ^a   Martin, Michelle T ^a   Tilton, Jessica J ^a   Touchette, Daniel R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG MISUSE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; LAW; MEDICAID; MEDICARE; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACY; REIMBURSEMENT; REVIEW; UNITED STATES;

HUMANS; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE PAYMENT SYSTEM; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 63449105316     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200969040-00001     Document Type: Review

References (80)

1. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52 (8): 1349-542.
2. Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly.Pharmacotherapy 2000; 20 (5): 575-82
3. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63 (2): 187-95
4. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288 (4): 455-61
5. Cramer J, Rosenheck R, Kirk G, et al. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003; 6 (5): 566-73
6. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288 (4): 462-7
7. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288 (22): 2880-3
8. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60 (7): 657-65
9. The Medicare Prescription Drug, Improvement, and Modernization Act, HR 1/ Pub. L. No. 108-173, 2003 Dec 8 [online]. Available from URL: http://www.cms.hhs.gov/MMAUp date/down loads/PL108-173summary.pdf [Accessed 2009 Mar 2]
10. Department of Health and Human Services - Centers for Medicare andMedicaid Services. 42 CFR Parts 400, 403, 411, 417, and 423 [CMS-4068-F] - FinalRule, Medicare program; Medicare prescription drug benefit, 2005 Jan 28 [online].Available from URL: http://www.cms.hhs.gov/quarterly providerupdates/downloads/CMS4068F.PDF [Accessed 2006 Jul 12]
11. Smith SR, Clancy CM. Medication therapy management programs: forming a new cornerstone for quality and safety in medicare. Am J Med Qual 2006; 21 (4): 276-9
12. Touchette DR, Burns AL, Bough MA, et al. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc (Wash DC) 2006; 46 (6): 683-91
13. Boyd ST, Boyd LC, Zillich AJ. Medication therapy management survey of the prescription drug plans. J AmPharm Assoc (2003) 2006; 46 (6): 692-9
14. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc (2003) 2005; 45 (5): 566-72
15. Anonymous. Summary of the executive sessions on medication therapy management programs: Bethesda, Maryland, June 14 and August 18, 2004. J Manag Care Pharm 2005; 11 (2): 179-86
16. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003) 2005; 45 (5): 573-9
17. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003) 2008; 48 (3): 341-53
18. Sound medication therapy management programs. J Manag Care Pharm 2006; 12 (3 Suppl.): S2-13
19. Anonymous. Sound medication therapy management programs, version 2.0 with validation study. J Manag Care Pharm 2008; 14 (1 Suppl. B): S2-44
20. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) 2007; 47 (5): 620-8
21. Omnibus Budget Reconciliation Act, HR 5835 (1990) [online]. Available from URL: http://thomas.loc.gov/ [Accessed 2009 Mar 2]
22. Disease Management Association of America. DMAA definition of disease management [online]. Available from URL: http://www.dmaa.org/dm-definition.asp [Accessed 2009 Mar 2]
23. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24 (3): 561-87
24. Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002; 25 (7): 1159-71
25. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41 (11): 1770-81
26. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother 2007; 41 (10): 1569-82
27. Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother 2008; 42 (9): 1195-207
28. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2000; (3): CD000336
29. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23 (1): 113-32
30. Schumock GT, Meek PD, Ploetz PA, et al. Economic evaluations of clinical pharmacy services: 1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy 1996; 16 (6): 1188-208
31. Lipton HL, Byrns PJ, Soumerai SB, et al. Pharmacists as agents of change for rational drug therapy. Int J Technol Assess Health Care 1995; 11 (3): 485-508
32. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother 2000; 34 (6): 772-87
33. Kozma CM, Reeder CE, Schulz RM. Economic pharmacists and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993; 15 (6): 1121-32
34. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) 2004; 44 (3): 337-49
35. Doucette WR, McDonough RP, Klepser D, et al. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005; 27 (7): 1104-11
36. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-24
37. Smith SR, Catellier DJ, Conlisk EA, et al. Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes. Am J Health Syst Pharm 2006; 63 (4): 372-9
38. Christensen DB, Roth M, Trygstad T, et al. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan. J Am Pharm Assoc (2003) 2007; 47 (4): 471-83
39. Isetts BJ, Schondelmeyer SW, Heaton AH, et al. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm 2006; 2 (1): 129-42
40. Isetts BJ, Brown LM, Schondelmeyer SW, et al. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163 (15): 1813-20
41. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003) 2008; 48 (2): 203-11
42. Hansen RA, Roth MT, Brouwer ES, et al. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. J Am Pharm Assoc (2003) 2006; 46 (6): 700-6
43. Schommer JC, Planas LG, Johnson KA, et al. Pharmacistprovided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc (2003) 2008; 48 (3): 354-63
44. Schommer JC, Planas LG, Johnson KA, et al. Pharmacistprovided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc (2003) 2008; 48 (4): 478-86
45. Tice B. What's in store for MTM? Chain Drug Rev 2008 Aug 18 [online]. Available from URL: http://findarticles. com/p/articles/mi-hb3007/is-14-30/ai- n28568002 [Accessed 2009 Mar 2]
46. Department of Health and Human Services - Centers for Medicare andMedicaid Services.Medicare Rx update: April 19 2006. Pharmacy quality alliance ⋯ now a reality [online]. Available from URL: http://www.cms.hhs.gov/Pharmacy/ downloads/update041906.pdf [Accessed 2009Mar 2]
47. Pharmacy Quality Alliance. Executive overview of the 2008 activities of the PQA cluster group on medication therapy management [online]. Available from URL: http://www. pqaalliance.org [Accessed 2008 Mar 10]
48. Pharmacy Quality Alliance. PQA announces official launch of demonstration projects [media release]. 2008 Jul 9 [online] Available from URL: http://www.pqaalliance.org/ files/PQALaunchofDemoProjectsJuly2008.pdf [Accessed 2009 Mar 2]
49. Pharmacy Quality Alliance. PQA call for proposals: demonstration projects (phase 1) [online]. Available from URL: http://www.pqaalliance.org/files/PQA- CEDISSEMINA TION-RFP.pdf [Accessed 2009 Mar 2]
50. Institute of Medicine. To err is human: building a safer health system. Washington, DC: Institute of Medicine, 2000
51. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine, 2001
52. Kairuz T, Bye L, Birdsall R, et al. Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging 2008; 25 (2): 153-62
53. Lowe CJ, Raynor DK, Purvis J, et al. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50 (2): 172-5
54. Zermansky AG, Petty DR, Raynor DK, et al. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess 2002; 6 (20): 1-86
55. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004; 170 (3): 345-9
56. Alvarez-Risco A, van Mil JW. Pharmaceutical care in community pharmacies: practice and research in Peru. Ann Pharmacother 2007; 41 (12): 2032-7
57. Bell JS, Vaananen M, OvaskainenH, et al. Providing patient care in community pharmacies: practice and research in Finland. Ann Pharmacother 2007; 41 (6): 1039-46
58. Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother 2005; 39 (11): 1911-7
59. Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother 2006; 40 (12): 2228-34
60. Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 2006; 40 (4): 729-35
61. Gastelurrutia MA, Faus MJ, Fernandez-Llimos F. Providing patient care in community pharmacies in Spain. Ann Pharmacother 2005; 39 (12): 2105-10
62. Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother 2006; 40 (3): 512-7
63. Herborg H, Sorensen EW, Frokjaer B. Pharmaceutical care in community pharmacies: practice and research in Denmark. Ann Pharmacother 2007; 41 (4): 681-9
64. Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother 2005; 39 (9): 1527-33
65. Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother 2007; 41 (5): 861-8
66. van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother 2005; 39 (10): 1720-5
67. Volmer D, Vendla K, Vetka A, et al. Pharmaceutical care in community pharmacies: practice and research in Estonia. Ann Pharmacother 2008; 42 (7): 1104-11
68. Westerlund LT, Bjork HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 2006; 40 (6): 1162-9
69. Yamamura S, Yamamoto N, Oide S, et al. Current state of community pharmacy in Japan: practice, research, and future opportunities or challenges. Ann Pharmacother 2006; 40 (11): 2008-14
70. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003; 43 (2): 173-84
71. Pharmacist Services Technical Advisory Coalition [online]. Available from URL: http://www.pstac.org/aboutus/ profsvc.html [Accessed 2007 Dec 22]
72. Brusig E, Davies W. PSTAC survey in 2006 was instrumental in obtaining permanent (category I) CPT codes for MTM services performed by pharmacists. J Manag Care Pharm 2008; 14 (1): 86-7
73. Isetts BJ, Buffington DE. CPT code-change proposal: national data on pharmacists' medication therapy management services. AmJ Health Syst Pharm 2007; 64 (15): 1642-6
74. Farmer AP, Legare F, Turcot L, et al. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2008; (3): CD004398
75. Moczygemba LR, Barner JC, Gabrillo ER, et al. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries. Am J Health Syst Pharm 2008; 65 (17): 1655-60
76. Currell R, Urquhart C, Wainwright P, et al. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD002098
77. Masica AL, Touchette DR, Dolor R, et al. Evaluation of a medication therapy management program on patient safety in Medicare beneficiaries at high risk of adverse drug events: study methods. In: Henriksen K, Battles JB, Keyes MA, et al., editors. Advances in patient safety. Vol. 4: technology and medication safety (AHRQ 08-0034-4). Rockville (MD): AHRQ, 2008 [online]. Available from URL: http:// www.ahrq.gov/qual/advances2/#v4 [Accessed 2009 Mar 2]
78. Kliethermes MA, Schullo-Feulner AM, Tilton J, et al. Model for medication therapy management in a university clinic. Am J Health Syst Pharm 2008; 65 (9): 844-56
79. McMahan R. Operationalizing MTM. through the use of health information technology. JManag Care Pharm 2008; 14 (2 Suppl.): S18-21
80. Herbert KE, Urmie JM, Newland BA, et al. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm 2006; 2 (3): 299-314